OVERVIEW: The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation focuses its scientific research grants on basic and clinical research into life-threatening illnesses.
IP TAKE: This funder does not award many grants each year, usually fewer than 20. Those seeking funding should expect competition.
PROFILE: Established in 2006, the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF) supports research scientists and investigators participating in “goal-directed basic and clinical research to prevent, reduce or eliminate disabling and life-threatening illness.” The foundation seeks to foster collaboration among biomedical researchers to hasten the pace of medical innovations and the commercialization of needed medical products. AMRF operates three main grantmaking programs: cancer research, immunological diseases, and neural repair and rehabilitation. In cancer research, the foundation prioritizes ubiquitin proteasome pathway, melanoma, and what it refers to as its core cancer program. In the study of immunological diseases, AMRF prioritizes inflammatory bowel syndrome.
Grants typically support large universities and medical research centers such as Harvard Medical School and Dana-Farber Cancer Institute. Amounts are often substantial, ranging from around $200,000 to upwards of $2 million. Awards are made for periods of one year and are renewable based on progress.
AMRF accepts unsolicited inquiries from researchers and investigators interested in joining the AMRF program as collaborating scientists. Submissions are accepted on a rolling basis throughout the year.